Spherical nucleic acid technology shows promising results in phase 0 trial in patients with glioblastoma at northwestern university

Chicago & cambridge, mass.--(business wire)--spherical nucleic acid technology shows promising results in phase 0 trial in patients with glioblastoma at northwestern university.

XCUR Ratings Summary

XCUR Quant Ranking